Publications by authors named "Vahid Karpisheh"

Claim this Profile
R
Retraction notice to "Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression" [Life Sci. 275 (2021) 119369].
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, Angelina Olegovna Zekiy, Mohsen Nabi Afjadi, Vahid Karpisheh

Life Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction notice to "Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells" [Int. J. Biol. Macromol. 167 (2021) 1006-1019].
Vahid Karpisheh, Javad Fakkari Afjadi, Mohsen Nabi Afjadi, Melika Sadat Haeri, Tayebeh Sadat Abdpoor Sough

Int J Biol Macromol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction notice to "Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo" [Int. J. Biol. Macromol. 186 (2021) 849-863].
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, Lyubov A Melnikova, Angelina Olegovna Zekiy

Int J Biol Macromol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1.
Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami, Ali Masjedi, Bentolhoda Rashidi, Vahid Karpisheh

Cancer Cell Int· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells" [Int. Immunopharmacol. 101 (2021) 108288].
Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi, Hossein Rasouli, Fariba Karoon Kiani, Vahid Karpisheh

Int Immunopharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of concern: "Different T cell related immunological profiles in COVID-19 patients compared to healthy controls" [Int. Immunopharmacol. 97 (2021) 107828].
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Balsam Qubais Saeed, Angelina Olegovna Zekiy, Lis M Yapanto

Int Immunopharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction notice to "Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models" [Life Sci. 288 (2022) 120166].
Fariba Karoon Kiani, Sepideh Izadi, Ehsan Ansari Dezfouli, Farbod Ebrahimi, Mohammad Mohammadi, Vahid Karpisheh

Life Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha.
Mohammad Sadeghi, Asma Moslehi, Hadiseh Kheiry, Fariba Karoon Kiani, Asieh Zarei, Vahid Karpisheh

Cancer Cell Int· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model.
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, Fariba Karoon Kiani, Mohammad Mohammadi

Pharm Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.
Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer, Armin Mahmoudsalehi Kheshti, Bentolhoda Rashidi, Vahid Karpisheh

Cell Commun Signal· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art.
Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary, Ala Amiri, Vahid Karpisheh

Cancer Cell Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia.
Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh, Atefeh Khodakarami, Hamed Mohammadi

IUBMB Life· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Armin Mahmoud Salehi, Kheshti, Farnaz Hajizadeh, Asal Barshidi, Bentolhoda Rashidi, Vahid Karpisheh

Pharm Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression.
Sepideh Izadi, Asma Moslehi, Hadiseh Kheiry, Fariba Karoon Kiani, Armin Ahmadi, Vahid Karpisheh

Pharm Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses.
Sara Adibfar, Ali Masjedi, Atefeh Nazer, Bentolhoda Rashidi, Vahid Karpisheh

Life Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model.
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, Fariba Karoon Kiani, Mohammad Mohammadi

Pharm Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular biology and therapeutic potential of Nrf2 in leukemia.
Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh, Shiva Abolhasani, Pooya Jalali

Cancer Cell Int· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Th17 cells in the pathogenesis and treatment of breast cancer.
Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh-Goudarzi, Mehran Mohammadpour Saray, Asal Barshidi

Cancer Cell Int· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Armin Mahmoud Salehi Kheshti, Farnaz Hajizadeh, Asal Barshidi, Bentolhoda Rashidi, Farbod Ebrahimi, Vahid Karpisheh

Pharm Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.
Fariba Karoon Kiani, Sepideh Izadi, Ehsan Ansari Dezfouli, Farbod Ebrahimi, Mohammad Mohammadi, Vahid Karpisheh

Life Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells.
Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi, Hossein Rasouli, Fariba Karoon Kiani, Vahid Karpisheh

Int Immunopharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies.
Sajjad Vakili-Samiani, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Alexei Valerievich Yumashev, Vahid Karpisheh

DNA Repair (Amst)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, Lyubov A Melnikova, Angelina Olegovna Zekiy

Int J Biol Macromol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Balsam Qubais Saeed, Angelina Olegovna Zekiy, Lis M Yapanto

Int Immunopharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression.
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, Angelina Olegovna Zekiy, Mohsen Nabi Afjadi, Vahid Karpisheh

Life Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis